BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35898476)

  • 1. Risk Factors and Prognostic Analysis of Gastrointestinal Stromal Tumor Recurrence-Metastasis.
    Chen S; Sang K; Chen W; Jin J; Chen X; Zhu G; Wang P; Cai Y
    Comput Math Methods Med; 2022; 2022():1127146. PubMed ID: 35898476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and prognostic analysis of postoperative recurrence or metastasis of low-risk gastrointestinal stromal tumors.
    Cao L; Lin C; Liu Y; Sui C; Li Z; Chen L; Guan W; Tao L; Tao T; Wang M; Wang F
    World J Surg Oncol; 2024 Feb; 22(1):65. PubMed ID: 38395931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor.
    Qu WZ; Wang L; Chen JJ; Wang Y
    World J Gastroenterol; 2023 Jul; 29(26):4200-4213. PubMed ID: 37475847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Online Dynamic Nomogram: Construction and Validation of a Predictive Model for Distant Metastasis Risk and Prognosis in Patients with Gastrointestinal Stromal Tumors.
    Wu H; Ding P; Wu J; Sun C; Guo H; Chen S; Lowe S; Yang P; Tian Y; Liu Y; Zhao Q
    J Gastrointest Surg; 2023 Jul; 27(7):1429-1444. PubMed ID: 37231240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Prognostic Nomogram for Recurrence-Free Survival of Patients With Primary Gastrointestinal Stromal Tumors After Surgical Resection: Combination of Prognostic Nutritional Index and Basic Variables.
    Li S; Chen D; Li S; Zhao Z; Yang H; Wang D; Zhang Z; Fu W
    Front Oncol; 2020; 10():581855. PubMed ID: 33585198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 7. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes].
    Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515
    [No Abstract]   [Full Text] [Related]  

  • 8. Performance of risk stratification systems for gastrointestinal stromal tumors: A multicenter study.
    Chen T; Ye LY; Feng XY; Qiu HB; Zhang P; Luo YX; Yuan LY; Chen XH; Hu YF; Liu H; Li Y; Tao KX; Yu J; Li GX
    World J Gastroenterol; 2019 Mar; 25(10):1238-1247. PubMed ID: 30886506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy.
    Yanagimoto Y; Takahashi T; Muguruma K; Toyokawa T; Kusanagi H; Omori T; Masuzawa T; Tanaka K; Hirota S; Nishida T
    Gastric Cancer; 2015 Apr; 18(2):426-33. PubMed ID: 24853473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
    Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
    Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts.
    Lin Y; Wang M; Jia J; Wan W; Wang T; Yang W; Li C; Chen X; Cao H; Zhang P; Tao K
    EBioMedicine; 2020 Oct; 60():103016. PubMed ID: 32980695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and prognosis analysis of 119 cases with giant gastrointestinal stromal tumor].
    Zhang P; Zeng X; Gao J; Liu W; Shuai X; Liu K; Liu X; Cai M; Cai K; Wang G; Tao K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1290-1295. PubMed ID: 27928802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of clinical features and prognostic factors on reoperation patients with postoperative recurrence or metastasis of gastrointestinal stromal tumor].
    Wang L; Xu W; Yao X; Yan C; Li C; Zhu Z; Liu W; Yan M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1274-1279. PubMed ID: 30506539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram to predict disease-free survival after surgical resection of GIST.
    Bischof DA; Kim Y; Behman R; Karanicolas PJ; Quereshy FA; Blazer DG; Maithel SK; Gamblin TC; Bauer TW; Pawlik TM
    J Gastrointest Surg; 2014 Dec; 18(12):2123-9. PubMed ID: 25245766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors for Primary Localized Gastrointestinal Stromal Tumors After Radical Resection: Shandong Gastrointestinal Surgery Study Group, Study 1201.
    Zhang X; Ning L; Hu Y; Zhao S; Li Z; Li L; Dai Y; Jiang L; Wang A; Chu X; Li Y; Yang D; Lu C; Yao L; Cui G; Lin H; Chen G; Cui Q; Guo H; Zhang H; Lun Z; Xia L; Su Y; Han G; Hui X; Wei Z; Sun Z; Shen S; Zhou Y
    Ann Surg Oncol; 2020 Aug; 27(8):2812-2821. PubMed ID: 32040699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment and prognosis of 108 patients with high-risk gastrointestinal stromal tumor].
    Lei C; Liu L; Wang Q; Wang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1300-1304. PubMed ID: 27928804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differences in clinicopathological features, gene mutations, and prognosis between primary gastric and intestinal gastrointestinal stromal tumors in 1061 patients].
    Li JX; Sun L; Zhao S; Shao B; Guo YH; Chen S; Liang H; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr; 26(4):346-356. PubMed ID: 37072312
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and external validation of a nomogram for individualized adjuvant imatinib duration for high-risk gastrointestinal stromal tumors: A multicenter retrospective cohort study.
    Liu R; Wu Y; Gong J; Zhao R; Li L; Wan Q; Lian N; Shen X; Xia L; Shen Y; Xiao H; Wu X; Chen Y; Cen Y; Xu X
    Cancer Med; 2022 Aug; 11(16):3093-3105. PubMed ID: 35297216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival.
    Xu SJ; Zhang SY; Dong LY; Lin GS; Zhou YJ
    BMC Cancer; 2021 Nov; 21(1):1170. PubMed ID: 34724907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.